2025-03-17 |
2025-03-14 |
A
Achat
|
Haurwitz Rachel E.
President and CEO
Administrateur exécutif
|
20 000
+0.6%
1,02
20 400 USD
|
20 000
+0.6%
|
1,02
|
20 400 USD
|
|
2025-02-21 |
2025-02-21 |
VP
Vente planifiée
|
MCCLUNG BARBARA G
Chief Legal Officer
Dirigeant
|
3 564
-0.8%
1,35
4 811 USD
|
3 564
-0.8%
|
1,35
|
4 811 USD
|
|
2025-02-21 |
2025-02-21 |
VP
Vente planifiée
|
Kanner Steven
Chief Scientific Officer
Dirigeant
|
3 564
-0.8%
1,35
4 811 USD
|
3 564
-0.8%
|
1,35
|
4 811 USD
|
|
2025-02-21 |
2025-02-21 |
VP
Vente planifiée
|
Khan Ruhi Ahmad
Chief Business Officer
Dirigeant
|
3 564
-5.1%
1,35
4 811 USD
|
3 564
-5.1%
|
1,35
|
4 811 USD
|
|
2025-01-30 |
2025-01-29 |
A
Achat
|
Ryali Sriram
Chief Financial Officer
Dirigeant
|
17 360
+inf%
1,42
24 651 USD
|
17 360
+inf%
|
1,42
|
24 651 USD
|
|
2023-01-20 |
2023-01-19 |
V
Vente
|
Rizvi Syed Ali-aamir
Chief Medical Officer
Dirigeant
|
5 627
-8.7%
6,31
35 506 USD
|
5 627
-8.7%
|
6,31
|
35 506 USD
|
|
2022-10-07 |
2022-10-06 |
V
Vente
|
Fischesser Ryan
VP of Finance and Controller
Dirigeant
|
10 000
-8.3%
10,80
107 958 USD
|
10 000
-8.3%
|
10,80
|
107 958 USD
|
|
2022-08-26 |
2022-08-25 |
VP
Vente planifiée
|
Kanner Steven
Chief Scientific Officer
Dirigeant
|
43 248
-12.5%
11,22
485 221 USD
|
43 248
-12.5%
|
11,22
|
485 221 USD
|
|
2022-01-12 |
2022-01-11 |
A
Achat
|
Fischesser Ryan
VP of Finance and Controller
Dirigeant
|
6 818
+6.7%
4,11
28 022 USD
|
6 818
+6.7%
|
4,11
|
28 022 USD
|
|
2022-01-12 |
2022-01-11 |
A
Achat
|
Fischesser Ryan
VP of Finance and Controller
Dirigeant
|
569
+0.6%
2,69
1 531 USD
|
569
+0.6%
|
2,69
|
1 531 USD
|
|
2021-12-21 |
2021-12-20 |
A
Achat
|
Fischesser Ryan
VP of Finance and Controller
Dirigeant
|
1 136
+1.1%
2,69
3 056 USD
|
1 136
+1.1%
|
2,69
|
3 056 USD
|
|
2021-12-08 |
2021-12-07 |
A
Achat
|
MCCLUNG BARBARA G
Chief Legal Officer
Dirigeant
|
6 115
+1.8%
2,69
16 449 USD
|
6 115
+1.8%
|
2,69
|
16 449 USD
|
|
2021-12-08 |
2021-12-07 |
A
Achat
|
MCCLUNG BARBARA G
Chief Legal Officer
Dirigeant
|
12
+0.0%
2,69
32 USD
|
12
+0.0%
|
2,69
|
32 USD
|
|
2021-10-21 |
2021-10-20 |
A
Achat
|
MCCLUNG BARBARA G
Chief Legal Officer
Dirigeant
|
43
+0.0%
2,69
116 USD
|
43
+0.0%
|
2,69
|
116 USD
|
|
2021-10-21 |
2021-10-20 |
A
Achat
|
MCCLUNG BARBARA G
Chief Legal Officer
Dirigeant
|
9 176
+2.8%
2,69
24 683 USD
|
9 176
+2.8%
|
2,69
|
24 683 USD
|
|
2021-10-13 |
2021-10-12 |
A
Achat
|
Kanner Steven
Chief Scientific Officer
Dirigeant
|
14 614
+7.3%
2,69
39 312 USD
|
14 614
+7.3%
|
2,69
|
39 312 USD
|
|
2021-10-13 |
2021-10-12 |
A
Achat
|
Kanner Steven
Chief Scientific Officer
Dirigeant
|
698
+0.3%
1,81
1 263 USD
|
698
+0.3%
|
1,81
|
1 263 USD
|
|
2021-10-13 |
2021-10-12 |
A
Achat
|
Kanner Steven
Chief Scientific Officer
Dirigeant
|
99 548
+99.4%
1,81
180 182 USD
|
99 548
+99.4%
|
1,81
|
180 182 USD
|
|
2021-10-12 |
2021-10-11 |
A
Achat
|
Fischesser Ryan
VP of Finance and Controller
Dirigeant
|
1 746
+1.8%
2,69
4 697 USD
|
1 746
+1.8%
|
2,69
|
4 697 USD
|
|